SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-21-046644
Filing Date
2021-04-05
Accepted
2021-04-05 17:00:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2112061-1_sc13da.htm SC 13D/A 44143
  Complete submission text file 0001104659-21-046644.txt   45507
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Subject) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-43603 | Film No.: 21806269
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences

Mailing Address 30 BLUE HERON DR. GREENWOOD VILLAGE CO 80121
Business Address
Scott John K Jr. (Filed by) CIK: 0001753763 (see all company filings)

Type: SC 13D/A